Clostridium difficile is a Gram-positive, spore-forming bacterium found in the gastrointestinal tract. Most people with C. difficile colonization are asymptomatic. However, antibiotic therapy can disrupt the balance of gut flora and lead to C. difficile infection. Older patients and those exposed to healthcare facilities are most at risk.

TransPharm has validated this pathogen in the following model:

• Gastrointestinal infection

Additional validations are available upon request.